IBM Common StockIBMWATCHMay 28, 2025Stock price when the opinion was issued
As of Jul 31, 2026. Market Open.
We had these stocks that were growing off of AI, and they've been delivering spectacular growth. But they've also had spectacular increases in share prices, which becomes a potential source of volatility.
The question is whether valuations are too high given projected growth? As we've seen here, some of the price adjustments can be pretty abrupt.
Growing from multiple angles, yet valuation still reasonable. Stable and embedded business complemented by new growth drivers. Consulting business helps companies implement AI, and that's where the real spending is. Strong in hybrid cloud, managing data across environments. Quantum computing already being used with potential for energy, healthcare, manufacturing.
Drop in February due to sector rotation and profit taking. Trades ~19x PE, attractive. Sees 30% upside from here to ~$317. Yield is 2.85%.
Hold on to it. At 4-5% growth, in the ballpark of the top players. He doesn't know its exposure to robotics. Street's pretty positive on it, about 20% upside. At 20x PE, not an aggressive valuation. Margins expected to stay healthy -- 60% gross margins, net income margins of close to 20%.
(Analysts’ price target is $314.00)
This is the next phase. We've been in this AI growth patch for a while now, which won't end, but quantum is the next level. It answers a lot of the problems that we deal with in the world such as medical issues and cybersecurity.
Problem is, not a lot of developed companies in the space. The industry is quite immature, but sometimes (if you have a longer time horizon) that's where you find opportunities for decent, long-term growth. Unlike AI, quantum needs a lot of space (perhaps it could solve office realty issues). IBM is starting to look more prominent in that space.